Get the Stockscreener App
7.33
1.35%
-0.10
Profound Medical Corp stock is traded at $7.33, with a volume of 62,290.
It is down -1.35% in the last 24 hours and up +13.29% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$7.43
Open:
$7.39
24h Volume:
62,290
Relative Volume:
0.59
Market Cap:
$221.32M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-5.4701
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
+11.06%
1M Performance:
+13.29%
6M Performance:
+15.80%
1Y Performance:
-1.35%
1-Day Range:
$7.10
$7.39
1-Week Range:
$6.50
$7.53
52-Week Range:
$3.76
$7.99
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.33 | 224.34M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
(PRN) Investment Performance Report (PRN:CA) - news.stocktradersdaily.com
Responsive Playbooks and the PROF Inflection - news.stocktradersdaily.com
(PRN) Optimized Trading Opportunities (PRN:CA) - news.stocktradersdaily.com
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet - Yahoo Finance
Profound Medical’s TULSA Procedure Gains Recognition at RSNA - TipRanks
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation - GlobeNewswire Inc.
Is Profound Medical Corp. stock supported by strong cash flowsVolume Spike & Daily Momentum Trading Reports - Newser
(PRN) Investment Analysis (PRN:CA) - news.stocktradersdaily.com
Is Profound Medical Corp. stock affected by interest rate hikesWeekly Risk Summary & Growth Focused Stock Pick Reports - Newser
Profound Medical (PROF) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Profound Medical Corp Launches TULSA-AI Volume Reduction Module - TradingView — Track All Markets
Profound Medical (PROF) Readies Launch of TULSA-AI Module for BP - GuruFocus
Profound Medical Unveils AI-Powered Module to Revolutionize BPH Treatment - TipRanks
Profound Medical Launches AI-Powered Module to Treat Benign Prostatic Hyperplasia - marketscreener.com
Profound Medical Brief: Launching AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings - marketscreener.com
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings - marketscreener.com
Profound Medical (NASDAQ: PROF) unveils AI BPH tool, sees TAM near 600,000 - Stock Titan
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - news.stocktradersdaily.com
Can Profound Medical Corp. stock sustain revenue growthJuly 2025 Highlights & High Accuracy Investment Signals - BỘ NỘI VỤ
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Profound Medical (NASDAQ:PROF) Raised to Hold at Wall Street Zen - Defense World
Where are the Opportunities in (PRN) (PRN:CA) - news.stocktradersdaily.com
Will Profound Medical Corp. stock keep outperforming rivals2025 Technical Patterns & Smart Investment Allocation Tips - newser.com
Why Profound Medical Corp. stock is seen as undervaluedTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Is Profound Medical Corp. stock gaining market share2025 Winners & Losers & High Win Rate Trade Tips - newser.com
How to use a screener to detect Profound Medical Corp. breakouts - newser.com
How to track smart money flows in Profound Medical Corp.2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Using data models to predict Profound Medical Corp. stock movementTrade Exit Summary & Consistent Growth Stock Picks - newser.com
Profound Medical Celebrates Milestone in Incision-Free Prostate Therapy - MSN
Why retail investors favor Profound Medical Corp. stock2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Wall Street Analysts Believe Profound Medical (PROF) Could Rally 97.59%: Here's is How to Trade - Yahoo Finance
Sentiment analysis tools applied to Profound Medical Corp.Earnings Recap Report & Low Risk Profit Maximizing Plans - newser.com
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease - The Manila Times
Using portfolio simulators with Profound Medical Corp. includedPortfolio Update Summary & Weekly High Return Forecasts - newser.com
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease - Investing News Network
Profound Medical’s Earnings Call Highlights Growth and Challenges - MSN
Profound Medical (PROF) Surpasses Q3 Revenue Expectations - GuruFocus
Profound Medical (PROF) Achieves Record Q3 Revenue and Growth - GuruFocus
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):